Upload
jean-warner
View
299
Download
1
Embed Size (px)
Citation preview
LOGO
Myocardial Extracellular Matrix Remodeling in Hea
rt Failure
Myocardial Extracellular Matrix Remodeling in Hea
rt Failure
王小蕾 高新营 王洁 王淳阅 石琳
Myocardial remodeling
Myocardial remodeling
Myocardial Stress↑
Myocyteremodeling
Non-myocyteremodeling
ECMremodeling
ECM remodeling in the heart
Collagen I ( 80% ) III ( 10-15% ) V ( <5% )
Components Fibronectin, Laminin, Elasin Function: interconnecting the cardiomyocytes maintaining ventricular shape, size, stiffness
Normal
Remodeling
Caused by the MMPs
The imbalance of degradation and synthesis of collagen
The MMPs and myocardial remodeling
The Matrix MetalloProteinases family(>20 kinds) Collagenases: MMP-1, MMP-8, MMP-13 Gelatinases: MMP-2, MMP-9
Abundant collagenases are present in the heart, but only 1%-2% of them are active in physiologicstatus
TIMP (Tissue Inhibitors of MetalloProteinases)
What are the MMPs?
The MMPs and myocardial remodeling
How do the MMPs work in the remodeling process?
MMPactivation
Myocardialremodeling
Myocardialstress↑
Clinical evidence: a 30-fold increase in collagenase and gelatinase activity
a decrease in TIMP to negligible levels
MMP activity in volume overload
Model: Chronic biventricular volume overload
using aorta-caval fistula rat model
Result : the post-fistula patho-physiologic course
1.The initial phase: 0-2 weeks, no deaths
2.The compensated hypertrophic phase: variable duration
3.The decompensated phase:100% dead by 30 weeks
Experiment
The AV fistula experiment
MMP activity * CVF
Ventricular
compliancecontractility size
Phase1 ↑↓in 3d
↑in 2w↑ ↓ ↑
Phase2 - - ↑ ↓ ↑
Phase3 ↑ ↑ ↓ ↑
* CVF: Collagen volume fraction
The AV fistula experiment
Phase1: MMP activity ↑ within 12h;
collagen volume fraction(CVF) ↓ by 3d,
quickly ↑ , above normal by 14d;
ventricular dilatation and hypertrophy by 7d;
ventricular compliance ↑ ,contractility ↓
Changes in the first phase
More compliant collagen III ↑Collagen cross-linking↓
The AV fistula experiment
Method of testing MMP activity
The AV fistula experiment
MMP activation in the early stages of injury or elevated wall stress and the consequent degradation of collagen are responsible for the initiation of a progressive remodeling process that leads to heart failure.
Conclusion
Role of cardiac mast cells in the activation of MMPs
In the AV fistula modle:
Mast cell density: 12h~5d
MMP activity: 12h~14d
the compensated hypertrophy phase
Mast cell stabilizing drug effectively prevents the LV dilatation, increased compliance and decreased contractility
>
Mature mast cell density
Role of cardiac mast cells in the activation of MMPs
remodeling normal
What is the
source for the
rapid increase
in mature mast density ?
Role of cardiac mast cells in the activation of MMPs
Mast cell degranulation
secreted substancesstimulate
maturation of mast cell
Myocardial stress ↑
The most possible source
Rapid maturation of resident cardiac mast cell precursors
Role of cardiac mast cells in the activation of MMPs
Reference
1. Joseph S. Janicki, Gregory L. Brower, Jason D. Gardner, Mary F. Forman, James A. Stewart, Jr., David B. Murray and Amanda L. Chancey, Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload, Cardiovascular Research, Volume 69, Issue 3, 15 February 2006, Pages 657-665
2. Anne M. Deschamps and Francis G. Spinale, Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation, Cardiovascular Research, Volume 69, Issue 3, 15 February 2006, Pages 666-676
3. Stefanie Gilles, Stefan Zahler, Ulrich Welsch,Christian P. Sommerhoff, Bernhard F. Becker, Release of TNF-a during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers, Cardiovascular Research,2003;60:608– 616
4. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001;11:372– 7
5. Dempsey PW, Doyle SE, He JQ, Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003;14:193–209
6. Stefanie Gilles, Stefan Zahler, Ulrich Welschb,Christian P. Sommerhoff, Bernhard F. Beckera, Release of TNF-a during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers, Cardiovascular Research, 60 ;2003:608– 616
7. Brower GL, Henegar JR, Janicki JS. Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol Heart Circ Physiol 1996;271:H2071– 8
8. Baicu CF, Stroud JD, Livesay VA, Hapke E, Holder J, Spinale FG, et al. Changes in extracellular collagen matrix alter myocardial systolic performance. Am J Physiol Heart Circ Physiol 2003;284:H122 – 32.
LOGO